Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -23.35% | -23.95% | -5.63% | 176.74% | -65.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -23.35% | -23.95% | -5.63% | 176.74% | -65.50% |
| Cost of Revenue | -38.03% | -37.38% | -11.76% | -76.96% | -19.32% |
| Gross Profit | -18.18% | -14.74% | -2.72% | 135.56% | -71.58% |
| SG&A Expenses | 498.81% | 14.33% | 60.54% | -35.02% | -35.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 309.69% | -25.46% | 53.44% | -39.94% | -39.14% |
| Operating Income | -328.49% | 25.53% | -56.59% | 41.88% | 36.42% |
| Income Before Tax | -237.60% | 17.58% | -32.25% | 57.92% | 36.25% |
| Income Tax Expenses | -- | 0.00% | -- | 87.50% | -- |
| Earnings from Continuing Operations | -237.60% | 17.56% | -32.25% | 57.83% | 36.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 128,387.50% | 8,155.56% | -- | -17.00% | -- |
| Net Income | -67.36% | 30.65% | -1.25% | 60.26% | 36.40% |
| EBIT | -328.49% | 25.53% | -56.59% | 41.88% | 36.42% |
| EBITDA | -394.90% | 29.75% | -68.92% | 47.62% | 39.78% |
| EPS Basic | 0.00% | 50.00% | 50.00% | 75.00% | 50.00% |
| Normalized Basic EPS | 100.00% | 100.00% | 0.00% | 50.00% | 50.00% |
| EPS Diluted | 0.00% | 50.00% | 50.00% | 75.00% | 50.00% |
| Normalized Diluted EPS | 100.00% | 100.00% | 0.00% | 50.00% | 50.00% |
| Average Basic Shares Outstanding | 49.47% | 51.60% | 46.86% | 42.33% | 28.11% |
| Average Diluted Shares Outstanding | 49.47% | 51.60% | 46.86% | 42.33% | 28.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |